Items per page
Sort by

Send to:

Choose Destination

Results: 6


Who's driving anyway? Herculean efforts to identify the drivers of breast cancer.

Hartmaier RJ, Priedigkeit N, Lee AV.

Breast Cancer Res. 2012 Oct 31;14(5):323. doi: 10.1186/bcr3325.


Improving ChIP-seq peak-calling for functional co-regulator binding by integrating multiple sources of biological information.

Osmanbeyoglu HU, Hartmaier RJ, Oesterreich S, Lu X.

BMC Genomics. 2012;13 Suppl 1:S1. doi: 10.1186/1471-2164-13-S1-S1. Epub 2012 Jan 17.


A SNP in steroid receptor coactivator-1 disrupts a GSK3β phosphorylation site and is associated with altered tamoxifen response in bone.

Hartmaier RJ, Richter AS, Gillihan RM, Sallit JZ, McGuire SE, Wang J, Lee AV, Osborne CK, O'Malley BW, Brown PH, Xu J, Skaar TC, Philips S, Rae JM, Azzouz F, Li L, Hayden J, Henry NL, Nguyen AT, Stearns V, Hayes DF, Flockhart DA, Oesterreich S.

Mol Endocrinol. 2012 Feb;26(2):220-7. doi: 10.1210/me.2011-1032. Epub 2011 Dec 15.


Nuclear receptor coregulator SNP discovery and impact on breast cancer risk.

Hartmaier RJ, Tchatchou S, Richter AS, Wang J, McGuire SE, Skaar TC, Rae JM, Hemminki K, Sutter C, Ditsch N, Bugert P, Weber BH, Niederacher D, Arnold N, Varon-Mateeva R, Wappenschmidt B, Schmutzler RK, Meindl A, Bartram CR, Burwinkel B, Oesterreich S.

BMC Cancer. 2009 Dec 14;9:438. doi: 10.1186/1471-2407-9-438.


Graduate students bring clinical know-how into their lab work through the HHMI Med into Grad program.

Hartmaier RJ, Shaffer DR.

Dis Model Mech. 2009 Nov-Dec;2(11-12):531-2. doi: 10.1242/dmm.004531. No abstract available.


A case of premature thelarche with no central cause or genetic variants within the estrogen receptor signaling pathway.

Hartmaier RJ, Walenkamp MJ, Richter AS, Wang J, Katzenellenbogen BS, Oesterreich S, Wit JM.

J Pediatr Endocrinol Metab. 2009 Aug;22(8):751-8.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk